Partner Article
Northwich Veterinary pharmaceutical company report gross profit up 5%
Northwich based veterinary pharmaceutical business Dechra Pharmaceuticals PLC report gross profit is up 5% at £56.9 million.
The cheshire based company released its half yearly report today, reporting strong revenue growth however profits have been influenced by strong currency headwinds.
The company report that currency problems will continue to affect its financial performance throughout the year.
The group have continued its expansion plans opening in Italy in March 2014 and begining trading in Canada in January 2015.
Chief Executive Officer, Ian Page, said: “The Group has made a solid start to the year with continued momentum in Europe and a strong performance in the US.
“Our focus on executing our strategy is delivering value to shareholders.
“Our core portfolio demonstrates growth, our product pipeline is delivering results and our global expansion is progressing well.”
This was posted in Bdaily's Members' News section by Sophia Taha .
The rise of an alternative investor model
Bots don't beat personal business coaching
From COVID-19 to the Middle East crisis
How to build credibility in B2B marketing
Is your business ready for the trade union change?
Government 'must take its foot off businesses' throats'
Upskilling key to civil engineering's future
Why apprenticeships are becoming a strategic asset
Business growth requires the right environment
OpenAI decision a wake-up call for our tech plans
Understanding the new Employment Rights Act
Why global conflict is a cyber risk for UK SMEs